Abstract
Dipyridamole is a potent coronary arteriolar vasodilator that has been employed in combination with thallium-201 imaging for the detection of coronary artery disease. Since a coronary stenosis may significantly reduce the regional coronary reserve without inducing ischemia, the presence of coronary artery disease can be documented by the different uptake of a flow tracer, such as thallium-201. Theoretically, myocardial ischemia is not required for the dipyridamole-thallium test to be positive. However, dipyridamole infusion can also induce myocardial ischemia in the presence of a coronary obstruction. This has been shown by a large amount of experimental and clinical evidence [1]. At a dosage of 0.75 mg/kg over 10 min, the electrocardiogram (ECG)-dipyridamole stress test has been proposed for the diagnosis of coronary artery disease, with a diagnostic accuracy comparable to the exercise stress test and an overall sensitivity (ECG changes and/or anginal pain) of about 80% (for a review, see ref [1]).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Picano E (1989) Dipyridamole-Echocardiography test: The historical background and the physiologic basis. Eur Heart J 10: 365–376.
Picano E, Distante A, Masini M, Morales MA, Lattanzi F, L’Abbate A (1985) Dipyridamole-echocardiography test in effort angina pectoris. Am J Cardiol 56: 452–56.
Picano, E, Simonetti I, Masini M, Lattanzi F, Marzilli M, Distante A, De Nes M, L’Abbate A (1986) Transient myocardial dysfunction during pharmacologic vasodilation as an index of reduced coronary reserve: a coronary hemodynamic and echocardiographic study. J Am Coll Cardiol 8: 84–90.
Picano, E, Pogliani M, Lattanzi F, Distante A, L’Abbate A (1989) Exercise capacity after acute aminophylline administration in angina pectoris. Am J Cardiol 63: 14–16.
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A (1988) Usefulness of the dipyridamole-exercise echocardiography test for diagnosis of coronary artery disease. Am J Cardiol 62: 67–71.
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A (1988) Aminophylline termination of dipyridamole stress as a trigger of coronary vasospasm in variant angina. Am J Cardiol 62: 694–98.
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate (1986) High dose dipyridamole echocardiography test in effort angina pectoris.J Am Cardiol Coll 8: 848–54.
Lattanzi F, Picano E, Masini M (1988) Safety of high dose dipyridamole echocardiography test. J Am Coll Cardiol 11 February (suppl): 217A, (abstracts).
Picano E, Lucarini AR, Lattanzi F, Distante A, Di Legge V, Salvetti A, L’Abbate A (1988) Dipyridamole-echocardiography test in essential hypertensives with chest pain. Hypertension 12: 238–242.
Masini M, Picano E, Lattanzi F, Distante A, L’Abbate (1988) High dose dipyridamole- echocardiography test in women: Correlation with exercise electrocardiography test and coronary angiography. J Am Coll Cardiol 12: 682–685.
Picano E, Morales MA, Distante A, Lattanzi F, Moscarelli E, Masini M, L’Abbate (1984) Dipyridamole echocardiography test in angina at rest: Noninvasive assessment of coronary stenosis underlying spasm. Am Heart J 111: 688–691.
Picano E, Masini M, Distante A, Simonetti I, Lattanzi F, Marzilli M, L’Abbate (1986) Dipyridamole-Echocardiography test in patients with exercise-induced ST segment elevation. Am J Cardiol 57: 765–770.
Picano E, Marraccini P, Lattanzi F, Levantesi D, Masini M, Dalle Vacche M, Distante A, L’Abbate A (1987) Dipyridamole echocardiography test as a clue to assess the organic ‘ceiling’ of individual coronary reserve. Eur Heart J 8: 38–42.
Picano E, Masini M, Lattanzi F, Klassen GA, Distante A, Levantesi D, Marraccini P, L’Abbate A (1988) Short term reproducibility of exercise testing in patients with ST segment elevation and different responses to the dipyridamole test. Br Heart J 60: 281–86.
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A (1987) Different degrees of ischemic threshold stratified by dipyridamole-echocardiography test. Am J Cardiol 59: 71–73.
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A (1987) Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol 60: 508–512.
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A (1987) Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol 60: 508–512.
Picano E, De Peri G, Salerno JA, Arbustini E, Distante A, Martinelli L, Pucci A, Montermartini C, Viganó M, Dorieto L (1990) Electrocardiographic changes suggestive of myocardial ischemic elicited by dipyridamole infusion in acute rejection only after heart transplantation. Circulation 81: 72–77.
Lattanzi F, Picano E, Masini M, De Prisco F, Distante A, L’Abbate A (1989) Transmitrai flow changes during dipyridamole-induced ischemia: A doppler-echocardiographic study. Chest 95: 1037–1042.
Picano E, Severi S, Michelassi C, Lattanzi F, Masini M, Orsini E, Distante A, L’Abbate A (1989) Prognostic importance of dipyridamole-echocardiography test in coronary artery disease 80: 450–457.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Picano, E., Lattanzi, F. (1991). Detection and assessment of the severity of coronary artery disease by dipyridamole echocardiography test. In: Iliceto, S., Rizzon, P., Roelandt, J.R.T.C. (eds) Ultrasound in Coronary Artery Disease. Developments in Cardiovascular Medicine, vol 113. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0611-2_6
Download citation
DOI: https://doi.org/10.1007/978-94-009-0611-2_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6762-1
Online ISBN: 978-94-009-0611-2
eBook Packages: Springer Book Archive